Recent accumulating evidence has revealed that GSCs can enhance radioresistance in GBM through activation of DNA damage checkpoint proteins, including checkpoint kinase 1 (Chk1), checkpoint kinase 2 (Chk2), ATM, structural maintenance of chromosomes (SMC1), and p53 [226]. The gene discussed is CHEK2; the disease is glioblastoma.